Search research articles
Contact Us
Filters
Showing results (21-30 of 474) with videos related to
Page
of 48
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
March 5, 2013
Evaluating effects of EPO in rodent behavioral assays related to depression
Catharine H Duman, Samuel S Newton
American Family Physician
|
November 9, 2005
Supporting self-management in patients with chronic illness
Mary Thoesen Coleman, Karen S Newton
Methods in Enzymology
|
January 1, 1981
Agaric acid
R A Freedland, R S Newton
CNS Drugs
|
August 19, 2007
Neurogenic actions of atypical antipsychotic drugs and therapeutic implications
Samuel S Newton, Ronald S Duman
Advanced Drug Delivery Reviews
|
April 11, 2022
Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines
Hannah S Newton, Marina A Dobrovolskaia
Hospital Formulary
|
February 1, 1976
The pharmacist: gatekeeper of the community's health
F S Mayer, D S Newton
Atherosclerosis
|
October 1, 1995
Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models
B R Krause, R S Newton
Current Neurovascular Research
|
September 27, 2005
Regulation of neurogenesis and angiogenesis in depression
Samuel S Newton, Ronald S Duman
Addiction (Abingdon, England)
|
March 8, 2016
Is it time to define minimally clinically important differences for patient-reported outcome measures used in alcohol brief intervention studies?
Amanda S Newton, Cameron T Wild
Nursing Times
|
July 10, 1985
A rewarding experience
T Harvey, P Green, S Newton
Page
of 48
Search research articles
Search
Showing results (21-30 of 474) with videos related to
Sort By:
Page
of 48
Methods in Molecular Biology (Clifton, N.J.)
|
March 5, 2013
Evaluating effects of EPO in rodent behavioral assays related to depression
Catharine H Duman, Samuel S Newton
American Family Physician
|
November 9, 2005
Supporting self-management in patients with chronic illness
Mary Thoesen Coleman, Karen S Newton
Methods in Enzymology
|
January 1, 1981
Agaric acid
R A Freedland, R S Newton
CNS Drugs
|
August 19, 2007
Neurogenic actions of atypical antipsychotic drugs and therapeutic implications
Samuel S Newton, Ronald S Duman
Advanced Drug Delivery Reviews
|
April 11, 2022
Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines
Hannah S Newton, Marina A Dobrovolskaia
Hospital Formulary
|
February 1, 1976
The pharmacist: gatekeeper of the community's health
F S Mayer, D S Newton
Atherosclerosis
|
October 1, 1995
Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models
B R Krause, R S Newton
Current Neurovascular Research
|
September 27, 2005
Regulation of neurogenesis and angiogenesis in depression
Samuel S Newton, Ronald S Duman
Addiction (Abingdon, England)
|
March 8, 2016
Is it time to define minimally clinically important differences for patient-reported outcome measures used in alcohol brief intervention studies?
Amanda S Newton, Cameron T Wild
Nursing Times
|
July 10, 1985
A rewarding experience
T Harvey, P Green, S Newton
Page
of 48